Bilirubin tests as risk predictors for cancer mortality, rheumatoid arthritis, Gilbert's syndrome and all-cause mortality

摘要

A new method for predicting the risk of future cancer mortality, rheumatoid arthritis and all-cause mortality is disclosed. The method uses serum bilirubin levels as indicator for such risks, lower serum bilirubin levels generally indicating increased risk and higher levels a decreased risk.